Childress Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.05M | Buy |
2,634
+141
| +6% | +$110K | 0.52% | 36 |
|
|
2025
Q1 | $2.06M | Buy |
2,493
+79
| +3% | +$65.3K | 0.6% | 31 |
|
|
2024
Q4 | $1.86M | Sell |
2,414
-31
| -1% | -$23.9K | 0.52% | 35 |
|
|
2024
Q3 | $2.17M | Buy |
2,445
+105
| +4% | +$93K | 0.58% | 32 |
|
|
2024
Q2 | $2.12M | Buy |
2,340
+60
| +3% | +$54.3K | 0.6% | 31 |
|
|
2024
Q1 | $1.77M | Sell |
2,280
-208
| -8% | -$162K | 0.52% | 38 |
|
|
2023
Q4 | $1.45M | Sell |
2,488
-23
| -0.9% | -$13.4K | 0.43% | 43 |
|
|
2023
Q3 | $1.35M | Buy |
2,511
+1,948
| +346% | +$1.05M | 0.44% | 41 |
|
|
2023
Q2 | $264K | Sell |
563
-511
| -48% | -$240K | 0.11% | 64 |
|
|
2023
Q1 | $369K | Sell |
1,074
-1,713
| -61% | -$588K | 0.16% | 59 |
|
|
2022
Q4 | $1.02M | Buy |
2,787
+62
| +2% | +$22.7K | 0.34% | 53 |
|
|
2022
Q3 | $892K | Sell |
2,725
-118
| -4% | -$38.6K | 0.35% | 54 |
|
|
2022
Q2 | $922K | Buy |
2,843
+210
| +8% | +$68.1K | 0.37% | 54 |
|
|
2022
Q1 | $755K | Buy |
2,633
+402
| +18% | +$115K | 0.26% | 70 |
|
|
2021
Q4 | $616K | Buy |
2,231
+57
| +3% | +$15.7K | 0.25% | 74 |
|
|
2021
Q3 | $502K | Buy |
2,174
+113
| +5% | +$26.1K | 0.2% | 93 |
|
|
2021
Q2 | $473K | Buy |
2,061
+340
| +20% | +$78K | 0.22% | 80 |
|
|
2021
Q1 | $321K | Buy |
1,721
+1,048
| +156% | +$195K | 0.15% | 122 |
|
|
2020
Q4 | $116K | Buy |
+673
| New | +$116K | 0.07% | 135 |
|